2-Picolinic Acid

2-Picolinic Acid

SCHEMBL1831091

CC(=O)C(=O)O.O=C(O)c1ccccn1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.80
L3MBTL1 Q9Y468 2/20 0.80
NAPRT Q6XQN6 1/20 0.80
P4HTM Q9NXG6 1/20 0.80
ALDH1A1 P00352 3/20 0.64
CES2 O00748 1/20 0.57
CES1 P23141 1/20 0.57
KMT2A Q03164 2/20 0.55
KDM4E B2RXH2 4/20 0.50
GSK3B P49841 1/20 0.48
CTNNB1 P35222 1/20 0.47
WNT3A P56704 1/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
PKM P14618 2/20 0.47
MAPT P10636 1/20 0.47
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MITF O75030 1/20 0.45
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Picolinic Acid SCHEMBL5694340 0.92 LMNA (0.87) LMNAL3MBTL1NAPRTP4HTMALDH1A1
2-Picolinic Acid SCHEMBL27945864 0.92 LMNA (0.87) LMNAL3MBTL1NAPRTP4HTMALDH1A1
2-Picolinic Acid SCHEMBL27658889 0.92 LMNA (0.87) LMNAL3MBTL1NAPRTP4HTMALDH1A1
2-Picolinic Acid SCHEMBL674837 0.89 LMNA (1.00) LMNAL3MBTL1NAPRTP4HTMALDH1A1
2-Picolinic Acid SCHEMBL29368665 0.89
2-Picolinic Acid SCHEMBL36055 0.89
2-Picolinic Acid SCHEMBL7457912 0.89 LMNA (1.00) LMNAL3MBTL1NAPRTP4HTMALDH1A1
2-Picolinic Acid SCHEMBL28737810 0.89 LMNA (1.00) LMNAL3MBTL1NAPRTP4HTMALDH1A1
2-Picolinic Acid SCHEMBL28065051 0.89 LMNA (0.74) LMNAL3MBTL1NAPRTP4HTMALDH1A1
2-Picolinic Acid SCHEMBL27634356 0.88 LMNA (0.80) LMNAL3MBTL1NAPRTP4HTMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234410-A1 COMBINATION PRODUCTS SIGMOID PHARMA LTD. (IE) 2014-08-21 US disclosed
EP-2322146-B1 Microcapsule formulations comprising two pharmaceutically active ingredients SIGMOID PHARMA LTD (IE) 2012-12-12 EP disclosed
EP-2444071-A1 Minicapsule formulations Sigmoid Pharma Limited (IE) 2012-04-25 EP disclosed
EP-2322146-A2 Microcapsule formulations comprising two pharmaceutically active ingredients Sigmoid Pharma Limited (IE) 2011-05-18 EP disclosed
EP-2156826-A1 Microcapsule formulations comprising two pharmaceutically active ingredients Sigmoid Pharma Limited (IE) 2010-02-24 EP disclosed
EP-2153824-A1 Seamless multiparticulate formulations Sigmoid Pharma Limited (IE) 2010-02-17 EP disclosed
US-20080113031-A1 seamless capsules having cores containing drugs, to enhance bioavailability, sustained release or time release of drugs SIGMOID PHARMA LIMITED (IE) 2008-05-15 US disclosed
US-20080020018-A1 Combination Products SIGMOID PHARMA LIMITED (IE) 2008-01-24 US disclosed
EP-1811979-A2 MICROCAPSULES COMPRISING A METHYLXANTHINE AND A CORTICOSTEROID Sigmoid Biotechnologies Limited (IE) 2007-08-01 EP disclosed
EP-1802287-A2 MINICAPSULE FORMULATIONS Sigmoid Biotechnologies Limited (IE) 2007-07-04 EP disclosed
WO-2006035418-A2 MICROCAPSULES COMPRISING A METHYLXANTHINE AND A CORTICOSTEROID SIGMOID BIOTECHNOLOGIES LIMITED (IE) 2006-04-06 WO disclosed
WO-2006035416-A2 MINICAPSULE FORMULATIONS SIGMOID BIOTECHNOLOGIES LIMITED (IE) 2006-04-06 WO disclosed